Insights

  • Date

  • Content Type

  • Reset

Blog

How our vaccines team supports innovation across global healthcare systems

8.11.22

By Michael Pfleiderer, PhD

Development of vaccines is a complex, evolving and highly specialized field that spans innovation, regulatory
Read More

Blog

Better late than never? What developers of SARS-CoV-2 vaccines in early-to -late-stage development should consider

12.05.21

By Michael Pfleiderer

Unfortunately, as of today the ongoing pandemic is still far from being under control, with close to 3...

Read More

Blog

The regulatory environment for the development of mRNA vaccines during COVID-19

7.12.20

By Ciaran Greene

A growing interest in mRNA-based technologies over the last decades has allowed the rapid development and deployment of...

Read More

Blog

Vaccine Development in Paediatric Populations – How to Proceed for SARS-CoV-2 Vaccines?

5.11.20

By Jerry Fuady

While adult clinical trials of SARS-CoV-2 vaccines have rapidly moved into Phase 3, no clinical trials have been...

Read More

Blog

How far are we with the accelerated development of SARS-CoV-2 vaccines – a review and outlook

13.08.20

By Noemi Lupo and Michael Pfleiderer

Development of SARS-CoV-2 vaccine comes with an unprecedented number of challenges ranging from CMC to clinical development. This...

Read More

Blog

Accelerated development and licensure of Coronavirus vaccines

28.02.20

By Michael Pfleiderer

The newly emerging 2019 novel Coronavirus is threatening the world as it spreads with a so far unprecedented...

Read More